WASHINGTON, DC — The chronic, excessive fragility of aging and sun-damaged skin has a name in the medical literature: dermatoporosis. This identification is helpful because it […]

The spread of human immunodeficiency virus 1 (HIV-1) infections increased despite restrictions on the border between Mexico and the United States during the COVID-19 pandemic, according […]

Patients with treatment-refractory cancers who did not meet eligibility criteria for a pan-cancer clinical trial but received waivers allowing them to participate had similar outcomes to […]

Moving for any new opportunity in medicine can feel like starting a new life, not just a new job. This is especially true for residency or […]

VIENNA — Safe and effective options for lowering serum uric acid (sUA) in patients with gout who are refractory to conventional therapies appear to be near, […]

As Pride Month drew to a close, the Supreme Court made a shocking announcement. For the first time in the history of the court, it is […]

Patients with early, triple-negative breast cancer (TNBC) and high risk of recurrence after initial therapy had significantly better 3-year overall survival (OS) when given adjuvant avelumab […]

Proton pump inhibitor (PPI) prophylaxis in patients undergoing mechanical ventilation can prevent upper gastrointestinal (GI) bleeding and appears to have no effect on mortality, according to […]

Potential harms and benefits should be weighed carefully before women and their physicians decide on breast cancer screening, according to updated guidelines from the Canadian Task […]